mothertobaby tirzepatide breastfeeding fact sheet While Breastfeeding: Safety & Guidelines Is Tirzepatide Safe While Breastfeeding?

World Journal of Diabetes, 11 (2), 2632

However, the model-based NMA sensitivity analysis included all available timepoints for change from baseline in weight (kg), allowing for comparisons at week 40, despite most studies concluding at week 26

What the label actually says The Mounjaro and Zepbound prescribing information states: "Available data with tirzepatide use in pregnant women are insufficient to evaluate for a drug-related risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes." The label then references animal studies: "Based on animal reproduction studies, there may be risks to the fetus from exposure to tirzepatide during pregnancy." And the recommendation: "Advise pregnant women of the potential risk to a fetus

A cycle develops where GI symptoms cause fluid loss, fluid loss causes fatigue, and fatigue reduces the motivation to stay on top of hydration